| Year |
Citation |
Score |
| 2019 |
Ramos JN, Hollinger K, Bengtsson NE, Allen JM, Hauschka SD, Chamberlain JS. Development of Novel Micro-dystrophins with Enhanced Functionality. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 30718090 DOI: 10.1016/J.Ymthe.2019.01.002 |
0.318 |
|
| 2018 |
Park JS, Vohra R, Klussmann T, Bengtsson NE, Chamberlain JS, Lee D. Non-invasive tracking of disease progression in young dystrophic muscles using multi-parametric MRI at 14T. Plos One. 13: e0206323. PMID 30365532 DOI: 10.1371/Journal.Pone.0206323 |
0.407 |
|
| 2017 |
Bengtsson NE, Hall JK, Odom GL, Phelps MP, Andrus CR, Hawkins RD, Hauschka SD, Chamberlain JR, Chamberlain JS. Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy. Nature Communications. 8: 14454. PMID 28195574 DOI: 10.1038/Ncomms14454 |
0.325 |
|
| 2017 |
Lee CH, Bengtsson N, Chrzanowski SM, Flint JJ, Walter GA, Blackband SJ. Magnetic Resonance Microscopy (MRM) of Single Mammalian Myofibers and Myonuclei. Scientific Reports. 7: 39496. PMID 28045071 DOI: 10.1038/Srep39496 |
0.541 |
|
| 2016 |
Bengtsson NE, Hall JK, Odom GL, Allen J, Chamberlain JR, Chamberlain JS. 501. In Vivo Gene Editing for Duchenne Muscular Dystrophy Molecular Therapy. 24: S199. DOI: 10.1016/S1525-0016(16)33310-X |
0.333 |
|
| 2015 |
Bengtsson NE, Hall JK, Lieber AM, Chamberlain JS. 613. Characterization of IPSC-Derived Myogenic Progenitors Isolated from Mouse Models of Duchenne Muscular Dystrophy Molecular Therapy. 23: S243-S244. DOI: 10.1016/S1525-0016(16)34222-8 |
0.377 |
|
| 2014 |
Seto JT, Bengtsson NE, Chamberlain JS. Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy. Current Pediatrics Reports. 2: 102-112. PMID 24883236 DOI: 10.1007/S40124-014-0044-X |
0.328 |
|
| 2012 |
Sharma P, Bengtsson NE, Walter GA, Sohn HB, Zhou G, Iwakuma N, Zeng H, Grobmyer SR, Scott EW, Moudgil BM. Gadolinium-doped silica nanoparticles encapsulating indocyanine green for near infrared and magnetic resonance imaging. Small (Weinheim An Der Bergstrasse, Germany). 8: 2856-68. PMID 22744832 DOI: 10.1002/Smll.201200258 |
0.614 |
|
| 2012 |
Mitra RN, Doshi M, Zhang X, Tyus JC, Bengtsson N, Fletcher S, Page BD, Turkson J, Gesquiere AJ, Gunning PT, Walter GA, Santra S. An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery. Biomaterials. 33: 1500-8. PMID 22078810 DOI: 10.1016/J.Biomaterials.2011.10.068 |
0.426 |
|
| 2011 |
Tallury P, Santra S, Sharma P, Matos BM, Bengtsson N, Biswas S, Saha AK, Walter GA, Scott EA, Moudgil BM. Fluorescent and paramagnetic chitosan nanoparticles that exhibit high magnetic resonance relaxivity: synthesis, characterization and in vitro studies. Journal of Biomedical Nanotechnology. 7: 724-9. PMID 22195491 DOI: 10.1166/Jbn.2011.1335 |
0.369 |
|
| 2011 |
Bengtsson NE, Kim S, Lin L, Walter GA, Scott EW. Ultra-high-field MRI real-time imaging of HSC engraftment of the bone marrow niche Leukemia. 25: 1223-1231. PMID 21494252 DOI: 10.1038/Leu.2011.72 |
0.591 |
|
| 2010 |
Sharma P, Singh A, Brown SC, Bengtsson N, Walter GA, Grobmyer SR, Iwakuma N, Santra S, Scott EW, Moudgil BM. Multimodal nanoparticulate bioimaging contrast agents. Methods in Molecular Biology (Clifton, N.J.). 624: 67-81. PMID 20217589 DOI: 10.1007/978-1-60761-609-2_5 |
0.601 |
|
| 2010 |
Bengtsson NE, Brown G, Scott EW, Walter GA. lacZ as a genetic reporter for real-time MRI. Magnetic Resonance in Medicine. 63: 745-53. PMID 20146234 DOI: 10.1002/Mrm.22235 |
0.596 |
|
| 2008 |
Sharma P, Brown SC, Bengtsson N, Zhang Q, Walter GA, Grobmyer SR, Santra S, Jiang H, Scott EW, Moudgil BM. Gold-Speckled Multimodal Nanoparticles for Noninvasive Bioimaging. Chemistry of Materials : a Publication of the American Chemical Society. 20: 6087-6094. PMID 19466201 DOI: 10.1021/Cm801020S |
0.59 |
|
| Show low-probability matches. |